1. Empagliflozin reduces body weight and indices of adipose distribution in patients with type 2 diabetes mellitus. (March 2016) Authors: Neeland, Ian J; McGuire, Darren K; Chilton, Robert; Crowe, Susanne; Lund, Søren S; Woerle, Hans J; Broedl, Uli C; Johansen, Odd Erik Journal: Diabetes & vascular disease research Issue: Volume 13:Number 2(2016:Mar.) Page Start: 119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials. (March 2015) Authors: Inzucchi, Silvio E; Zinman, Bernard; Wanner, Christoph; Ferrari, Roberto; Fitchett, David; Hantel, Stefan; Espadero, Rosa-Maria; Woerle, Hans-Jürgen; Broedl, Uli C; Johansen, Odd Erik Journal: Diabetes & vascular disease research Issue: Volume 12:Number 2(2015:Mar.) Page Start: 90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗